Data derived from most recent annual or quarterly report
Market Cap	944.304 Million	Shares Outstanding	139.69 Million	Avg 30-day Volume	7.469 Million
P/E Ratio	0.0	Dividend Yield	0.0	EPS	-0.14
Price to Revenue	0.0	Debt to Equity	0.0	EBITDA	-82.08 Million
Price to Book Value	2.321	Operating Margin	0.0	Enterprise Value	275.054 Million
Current Ratio	8.964	EPS Growth	0.036	Quick Ratio	8.742
1 Yr BETA	1.2158	52-week High/Low	0.0 /	Profit Margin	0.0
Operating Cash Flow Growth	15.0002	Altman Z-Score	11.0691	Free Cash Flow to Firm	-46.274 Million

Funds Holding ACHN (via 13F filings)

Quarter to view: Refresh Download CSV Download Excel (.xlsx) Download TSV

Market Value:

Ranking:

% of portfolio

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ACHN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

4: filed on 2020-01-30 by G1 EXECUTION SERVICES, LLC

3: filed on 2020-01-30 by G1 EXECUTION SERVICES, LLC

4: filed on 2020-01-29 by VITULLO NICOLE

4: filed on 2019-02-11 by Di Donato Brian

3: filed on 2019-02-11 by Di Donato Brian

4: filed on 2019-01-25 by VERWIEL FRANK

4: filed on 2019-01-25 by VAN NOSTRAND ROBERT L

4: filed on 2019-01-25 by SCHEER DAVID

4: filed on 2019-01-25 by KISHBAUCH MICHAEL D

4: filed on 2019-01-25 by GRAVES KURT

Events (8k)

8-K: filed on 2020-01-28:

Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2020-01-24:

Item 8.01: Other Events

8-K: filed on 2020-01-16:

Item 8.01: Other Events

8-K: filed on 2019-12-19:

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits
Item 5.07: Submission of Matters to a Vote of Security Holders

8-K: filed on 2019-10-16:

Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2019-09-17:

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

8-K: filed on 2019-08-08:

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2019-05-17:

Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2019-05-09:

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2019-03-07:

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Proposed Sales (Form 144)

Proxy

Prospectus

All

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name	Type	Last Reported Shares Held	Last Reported Date
G1 EXECUTION SERVICES, LLC SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC SUSQUEHANNA SECURITIES, LLC	10% Owner	No longer subject to file	2020-01-28
VITULLO NICOLE	Director	No longer subject to file	2020-01-28
DI DONATO BRIAN CHIEF FINANCIAL OFFICER	Officer	0	2019-02-11
KISHBAUCH MICHAEL D	Director	0	2019-01-23
FISHERMAN JASON S	Director	0	2019-01-23
VAN NOSTRAND ROBERT L	Director	0	2019-01-23
MANNING MARTHA E GENERAL COUNSEL	Officer	0	2019-01-23
SCHEER DAVID	Director	0	2019-01-23
GRAVES KURT	Director	0	2019-01-23
TRUITT JOSEPH CHIEF EXECUTIVE OFFICER	Officer Director	0	2019-01-23
VERWIEL FRANK	Director	0	2019-01-23
ZELENKOFSKE STEVEN CHIEF MEDICAL OFFICER	Officer	0	2019-01-23
FIRUTA PAUL E CHIEF OPERATING OFFICER	Officer	0	2019-01-23
GIBNEY ANTHONY S CHIEF BUSINESS OFFICER	Officer	0	2019-01-23
LANTZ KERI SEE REMARKS	Officer	0	2019-01-23
FRASHIER GARY E	Director	0	2018-02-09
DESHPANDE MILIND CHIEF EXECUTIVE OFFICER	Officer Director	0	2018-02-09
FENTON MARY KAY CHIEF FINANCIAL OFFICER	Officer	0	2018-02-09
JOHNSON & JOHNSON JOHNSON & JOHNSON INNOVATION - JJDC, INC.	10% Owner	No longer subject to file	2017-11-20
APELIAN DAVID CHIEF MEDICAL OFFICER	Officer	0	2017-01-17
BARRISH JOEL C CHIEF SCIENTIFIC OFFICER	Officer	0	2017-01-17
SHAH GAUTAM EVP AND CHIEF COMPLIANCE OFC.	Officer	0	2014-12-02
LIOTTA DENNIS	Director	0	2014-12-02
RA CAPITAL MANAGEMENT, LLC KOLCHINSKY PETER RA CAPITAL HEALTHCARE FUND LP	FORMER 10% OWNER, SEE FN(5)(6)FORMER 10% OWNER, SEE FN(5)(6)FORMER 10% OWNER, SEE FN(5)(6)	No longer subject to file	2014-09-29
RA CAPITAL MANAGEMENT, LLC	10% Owner SEE FOOTNOTES (1)(5)	22,486,007	2014-06-20
QVT ASSOCIATES GP LLC	10% Owner	No longer subject to file	2014-06-16
QVT ASSOCIATES GP LLC QVT FUND V LP	10% Owner	11,712,953	2013-09-30
TREU JESSE I	10% Owner	6,017,025	2013-01-18
BLAIR JAMES C	10% Owner	6,017,025	2013-01-18
DOVEY BRIAN H	10% Owner	6,017,025	2013-01-18
SCHOEMAKER KATHLEEN K	10% Owner	6,017,025	2013-01-18
HALAK BRIAN K	10% Owner	6,017,025	2013-01-18
DOMAIN PARTNERS VIII, L.P.	10% Owner	5,772,968	2013-01-18
WRIGHT DAVID P	Director	0	2012-12-18
CLARUS LIFESCIENCES II, L.P. CLARUS VENTURES II GP, L.P. CLARUS VENTURES II, LLC LIPTAK ROBERT HENNER DENNIS GALAKATOS NICHOLAS WHEELER KURT STEINMETZ MICHAEL	10% Owner	No longer subject to file	2012-06-04
SIMON NICHOLAS	Director	73,593	2012-06-04
CLARUS LIFESCIENCES II, L.P. CLARUS VENTURES II GP, L.P. CLARUS VENTURES II, LLC LIPTAK ROBERT SIMON NICHOLAS HENNER DENNIS GALAKATOS NICHOLAS WHEELER KURT STEINMETZ MICHAEL	Director 10% Owner	10,942,471	2012-05-31
OLEK ELIZABETH A SVP AND CMO	Officer	2,000	2012-01-10
QUAKER BIOVENTURES II LP	10% Owner	No longer subject to file	2011-03-07
KAMDAR KIM P.	10% Owner	25,000	2011-01-01
DOMAIN ASSOCIATES	10% Owner	25,000	2010-10-06
DP VIII ASSOCIATES, L.P.	10% Owner	59,161	2010-08-20
CLARUS LIFESCIENCES II, L.P. CLARUS VENTURES II GP, L.P. CLARUS VENTURES II, LLC LIPTAK ROBERT SIMON NICHOLAS HENNER DENNIS GALAKATOS NICHOLAS LEIDEN JEFFREY WHEELER KURT STEINMETZ MICHAEL	Director 10% Owner	4,386,577	2010-01-11
INVESTOR AB INVESTOR GROWTH CAPITAL LTD	10% Owner	No longer subject to file	2009-12-31
GREY MICHAEL G	Director	0	2009-12-18
MOORIN JAY SCHREIBER ALAIN PROQUEST ASSOCIATES IV LLC PROQUEST INVESTMENTS IV, L.P.	10% Owner	No longer subject to file	2009-12-16
INVESTOR GROWTH CAPITAL LTD	10% Owner	1,783,862	2008-12-04
INVESTOR AB	10% Owner	2,323,660	2008-08-12
FORMELA JEAN FRANCOIS	Director 10% Owner	15,000	2007-12-14
GARVEY JAMES M	Director 10% Owner	15,000	2007-12-14
POTTAGE JOHN C JR SVP AND CHIEF MEDICAL OFFICER	Officer	40,000	2006-12-19
SCHRODER VENTURE MANAGERS LTD SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II LP1 SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II L.P.2 SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II STRATEGIC PARTNERS L.P. SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II L.P.3 SV (NOMINEES) LTD AS NOMINEE OF SCHRODER VENTURES INVESTMENTS LTD SCHRODER VENTURES MANAGERS INC SITCO NOMINEES LTD. VC 01903 AS NOMINEE OF SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II GROUP CO-INVESTMENT SCHEME	10% Owner	1,710,231	2006-10-31
ADVENT INTERNATIONAL CORP/MA	MEMBER OF GROUP NO LONGER >10%	1,116,432	2006-10-31
GILEAD SCIENCES INC	10% Owner	0	2006-10-25
ATLAS VENTURE FUND V LP ATLAS VENTURE ENTREPRENEURS FUND V LP ATLAS VENTURE PARALLEL FUND V-A C V ATLAS VENTURE ASSOCIATES V LP	10% Owner	0	2006-10-25
RYSER STEFAN	Director	0	2006-10-25
ADVENT PARTNERS HLS II LIMITED PARTNERSHIP	MEMBER OF GROUP > 10%	0	2006-10-25
ADVENT PARTNERS LIMITED PARTNERSHIP	MEMBER OF GROUP > 10%	0	2006-10-25
ADVENT INTERNATIONAL LIMITED PARTNERSHIP	MEMBER OF GROUP > 10%	0	2006-10-25
ADVENT HEALTHCARE & LIFE SCIENCES II LP	MEMBER OF GROUP > 10%	0	2006-10-25
ADVENT HEALTHCARE & LIFE SCIENCES II KG	MEMBER OF GROUP > 10%	0	2006-10-25
WHITE CHRISTOPHER A	Director	0	2006-10-25

Insider Transactions Last 60 Days

Reporting Owners	Filing Date	Trans Date	Trans Code	Shares	Share Price	Acquired Disposed	Shares Owned after	D/I	10b5	Perf 1d*	Perf 5d*	Perf 1m*	Max Gain	Max Gain Days	Max Loss	Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code	Definition
A	Grant, award or other acquisition pursuant to Rule 16b-3(d)
C	Conversion of derivative security
D	Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E	Expiration of short derivative position
F	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G	Bona fide gift
H	Expiration (or cancellation) of long derivative position with value received
I	Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J	Other acquisition or disposition
L	Small acquisition under Rule 16a-6
M	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O	Exercise of out-of-the-money derivative security
P	Open market or private purchase of non-derivative or derivative security
S	Open market or private sale of non-derivative or derivative security
U	Disposition pursuant to a tender of shares in a change of control transaction
W	Acquisition or disposition by will or the laws of descent and distribution
X	Exercise of in-the-money or at-the-money derivative security
Z	Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security	Date/Time	Rebate Rate	Fee Rate	Shares Available

Current Active Short Positions

Holder	Issuer	Net Short Position	Position Date	Origin

Achillion Pharmaceuticals Inc YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Achillion Pharmaceuticals Inc (ACHN)

Are you looking for this stock instead?

Funds Holding ACHN (via 13F filings)

Filter by:

Mutual Funds Holding ACHN

Active Schedule 13D and 13G filings

Recent Filings

Financial Reporting

Ownership

Events (8k)

Proposed Sales (Form 144)

Proxy

Prospectus

All

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

Open Market Sells (S)

Exercise Derivative Conversion (M)

Current/Former Insiders

Insider Transactions Last 60 Days

IBR Securities Loan Availability

Current Active Short Positions

No recent transactions

* To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page*

Elevate your investments

Achillion Pharmaceuticals Inc (ACHN)

Are you looking for this stock instead?

Funds Holding ACHN (via 13F filings)

Filter by:

Mutual Funds Holding ACHN

Active Schedule 13D and 13G filings

Recent Filings

Financial Reporting

Ownership

Events (8k)

Proposed Sales (Form 144)

Proxy

Prospectus

All

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

Open Market Sells (S)

Exercise Derivative Conversion (M)

Current/Former Insiders

Insider Transactions Last 60 Days

IBR Securities Loan Availability

Current Active Short Positions

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments

* To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page*